Seth A Strope

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. pmc Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Mo Electronic address
    Urology 86:1115-22. 2015
  2. doi request reprint Comparative effectiveness research in urologic cancers
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO, USA
    Cancer Treat Res 164:221-35. 2015
  3. pmc Survival impact of followup care after radical cystectomy for bladder cancer
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Missouri Electronic address
    J Urol 190:1698-703. 2013
  4. pmc Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 80:84-9. 2012
  5. pmc Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Missouri 63110, USA
    J Urol 187:1341-5. 2012
  6. doi request reprint Update on chemoprevention for prostate cancer
    Seth A Strope
    Division of Urology, Washington University, 4960 Children s Place, Saint Louis, MO 63110, USA
    Curr Opin Urol 20:194-7. 2010
  7. pmc Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population
    Seth A Strope
    Division of Urology Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 78:3-9. 2011
  8. pmc Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 77:535-40. 2011
  9. pmc Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation
    Adam S Bellinger
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri, USA
    J Urol 187:1739-46. 2012
  10. ncbi request reprint Impact of different definitions of high-risk prostate cancer on survival after radical prostatectomy
    Kenneth Gerard Nepple
    Washington University School of Medicine, St Louis, MO Cleveland Clinic, Cleveland, OH
    J Clin Oncol 30:113. 2012

Collaborators

Detail Information

Publications26

  1. pmc Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Mo Electronic address
    Urology 86:1115-22. 2015
    ....
  2. doi request reprint Comparative effectiveness research in urologic cancers
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO, USA
    Cancer Treat Res 164:221-35. 2015
    ..We will review progress made in comparative effectiveness research for each cancer and outline important topics where future research is needed. ..
  3. pmc Survival impact of followup care after radical cystectomy for bladder cancer
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Missouri Electronic address
    J Urol 190:1698-703. 2013
    ..Due to substantial variation in patient followup after radical cystectomy for bladder cancer, we sought to understand the effect of urine and laboratory tests, physician visits and imaging on overall survival...
  4. pmc Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 80:84-9. 2012
    ..To determine the impact of evaluative care guideline compliance on surgical intervention for benign prostatic hyperplasia (BPH)...
  5. pmc Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia
    Seth A Strope
    Division of Urology, Department of Surgery, Washington University, St Louis, Missouri 63110, USA
    J Urol 187:1341-5. 2012
    ..We assessed the comparative effectiveness of 2 common forms of surgical therapy, transurethral prostate resection and laser therapy, for benign prostatic hyperplasia...
  6. doi request reprint Update on chemoprevention for prostate cancer
    Seth A Strope
    Division of Urology, Washington University, 4960 Children s Place, Saint Louis, MO 63110, USA
    Curr Opin Urol 20:194-7. 2010
    ..Interest in prostate cancer prevention and risk reduction continues among both patients and clinicians. Recent studies on primary and secondary prevention of prostate cancer will be addressed...
  7. pmc Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population
    Seth A Strope
    Division of Urology Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 78:3-9. 2011
    ..We evaluated the trends in use of BPH-related evaluative tests and the extent to which urologists comply with the guidelines for these evaluative tests...
  8. pmc Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia
    Seth A Strope
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Urology 77:535-40. 2011
    ..As the medical and surgical specialists for men with lower urinary tract symptoms (LUTS), urologists provide testing to evaluate symptoms and determine therapy...
  9. pmc Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation
    Adam S Bellinger
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri, USA
    J Urol 187:1739-46. 2012
    ..We determined expenditure trends for benign prostatic hyperplasia evaluative testing after urologist consultation and placed these trends in the context of overall Medicare expenditures...
  10. ncbi request reprint Impact of different definitions of high-risk prostate cancer on survival after radical prostatectomy
    Kenneth Gerard Nepple
    Washington University School of Medicine, St Louis, MO Cleveland Clinic, Cleveland, OH
    J Clin Oncol 30:113. 2012
    ..We applied six previously described high risk definitions to men treated with radical prostatectomy and evaluated their ability to predict survival outcomes in a multi-institutional cohort...
  11. pmc Trends in the utilization of imaging for upper tract urothelial carcinoma
    Anand Mohapatra
    Division of Urologic Surgery, School of Medicine, Washington University in St Louis, St Louis, Mo Electronic address
    Urol Oncol 34:236.e23-8. 2016
    ..To evaluate the changes in use of the different imaging modalities for diagnosing upper tract urothelial carcinoma (UTUC) and assess how these changes have affected tumor stage at the time of surgery...
  12. doi request reprint Exploring SEER-Medicare for changes in the treatment of laryngeal cancer among elderly medicare beneficiaries
    Raymond A Jean
    Department of Otolaryngology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA
    Otolaryngol Head Neck Surg 150:419-27. 2014
    ..To explore the change in frequency of treatment, and its association with 5-year survival, among elderly Medicare enrollees with squamous cell carcinoma of the larynx (SCCL)...
  13. pmc The impact of technology diffusion on treatment for prostate cancer
    Florian R Schroeck
    Department of Urology, Division of Health Services Research Department of Urology, Division of Urologic Oncology, University of Michigan, Ann Arbor, MI Departments of Urology and Epidemiology and Health Policy Research, University of Florida College of Medicine, Gainesville, FL Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO
    Med Care 51:1076-84. 2013
    ..The use of local therapy for prostate cancer may increase because of the perceived advantages of new technologies such as intensity-modulated radiotherapy (IMRT) and robotic prostatectomy...
  14. pmc Limited use of surveillance imaging following nephrectomy for renal cell carcinoma
    Eric H Kim
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO
    Urol Oncol 34:237.e11-8. 2016
    ..To evaluate the utilization of follow-up imaging after nephrectomy for renal cell carcinoma (RCC) in nationally representative data...
  15. pmc Sources of variation in follow-up expenditure after radical cystectomy
    Goutham Vemana
    Division of Urology, Department of Surgery, Washington University, St Louis, MO
    Urol Oncol 33:267.e31-7. 2015
    ..We sought to determine sources of these variations in care as well as examine the economic effect of standardization of care to guideline-recommended care...
  16. pmc Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity
    Kenneth G Nepple
    Washington University School of Medicine, St Louis, MO, USA
    Eur Urol 64:372-8. 2013
    ..Large-scale comparative evaluation of PCa mortality (PCM) and overall mortality (OM) restricted to men without comorbidity at the time of treatment has not been performed...
  17. pmc Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer
    Kenneth G Nepple
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
    Urol Oncol 31:894-8. 2013
    ..We compared pathology, recurrence, and survival in a single surgeon series of open and robotic cystectomy since the introduction of robotic cystectomy...
  18. ncbi request reprint Impact of marital status on prostate cancer-specific mortality and overall mortality after radical prostatectomy
    Kenneth Gerard Nepple
    Washington University School of Medicine, St Louis, MO
    J Clin Oncol 30:73. 2012
    ..We investigated the association between marital status and both prostate cancer specific mortality (PCSM) and overall mortality (OM) in men treated with radical prostatectomy...
  19. doi request reprint Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10
    Eric H Kim
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO
    Urology . 2016
    ..To determine the added value of prostate magnetic resonance imaging (MRI) to the Prostate Cancer Prevention Trial risk calculator...
  20. pmc Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data
    Goutham Vemana
    Department of Surgery, Division of Urology, Washington University in St Louis, School of Medicine, St Louis, MO
    Urology 95:115-20. 2016
    ..To determine survival differences among patients receiving endoscopic vs surgical management for upper tract urothelial carcinoma (UTUC)...
  21. pmc Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care
    Goutham Vemana
    Division of Urology, Barnes Jewish Hospital Washington University in St Louis, School of Medicine, St Louis, Missouri Electronic address
    J Urol 192:43-9. 2014
    ..However, not all patients undergoing cystectomy are eligible for this therapy. We establish the maximum proportion of patients expected to receive neoadjuvant chemotherapy if all those eligible had a consultation with medical oncology...
  22. doi request reprint Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA
    Brandon J Manley
    Washington University School of Medicine, Division of Urology, St Louis, Missouri, USA
    Int Braz J Urol 43:. 2017
    ....
  23. doi request reprint Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006
    Kenneth G Nepple
    Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Urol 187:32-8. 2012
    ..An increase in kidney cancer was reported in the United States but overall rates may obscure trends in age specific groups. We explored whether the increase in kidney cancer incidence differs across age groups...
  24. pmc A population-based analysis of contemporary rates of reoperation for penile prosthesis procedures
    Shaun Grewal
    Division of Urology, Department of Surgery, Washington University in St Louis, St Louis, Mo Electronic address
    Urology 84:112-6. 2014
    ..To perform a population-based comparison of inflatable vs semirigid penile prostheses and to determine contemporary rates of reoperation and identify factors impacting the type of prosthetic implanted...
  25. pmc Encrusted cystitis
    Michael H Johnson
    Division of Urologic Surgery, Barnes Jewish Hospital Washington University School of Medicine, St Louis, MO 63110, USA
    Urology 79:e31-2. 2012
    ..Urea-splitting bacteria, most commonly Corynebacterium urealyticum, are the causative pathogen. Treatment is a combination of antibiotics, urine acidification, and endoscopic removal of encrustations...
  26. doi request reprint Prostate cancer screening: current status and future perspectives
    Seth A Strope
    Washington University School of Medicine, Barnes Jewish Hospital, Siteman Cancer Center, 4960 Children s Place, St Louis, MO 63110, USA
    Nat Rev Urol 7:487-93. 2010
    ..Strategies such as the use of 5alpha-reductase inhibitors in high-risk patients, and the continued development of urinary and genetic markers hold promise in this regard...